Viemed Healthcare, Inc.

Viemed Healthcare, Inc.

VMDยทNASDAQ

$9.56

+0.84%
HealthcareMedical - Devices

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

At a Glance

Live Snapshot
Market Cap$366.50M
EPS0.3800
P/E Ratio25.16
Earnings Date08/05/2026
3Y+95.0%
5Y+106.0%
10Y+762.0%
3Y+140.0%
5Y-53.0%
10Y+1116.0%
3Y+87.0%
5Y+48.0%
10Y+709.0%
Viemed Healthcare, Inc.

Viemed Healthcare, Inc. Profit Bridge

VMD ยท NASDAQ
Revenue270.28M
Cost of Goods Sold (116.31M)
Gross Profit153.97M
Operating Expenses (132.14M)
Operating Income21.83M
Interest Expense (1.18M)
Other Income/Expense-67.00K
Pretax Income21.77M
Income Tax (6.39M)
Net Income14.93M
Net Income
14.93M

Profitability Analysis

Gross Margin

57.0%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

8.1%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

5.5%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

29.4%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

Viemed Healthcare, Inc. Income Statement

VMD โ€ข NASDAQ

Viemed Healthcare, Inc. Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
REVENUE
270.3M
224.3M
183M
138.8M
117.1M
131.3M
80.3M
65.3M
46.9M
31.4M
34.6M
23.3M
GROSS PROFIT
(116.3M)
(91.1M)
(70.2M)
(54.2M)
(43.7M)
(51.2M)
(24.3M)
(16.7M)
(12.3M)
(12.5M)
(7.8M)
(3.9M)
154M
133.2M
112.8M
84.7M
73.4M
80.1M
56M
48.6M
34.6M
18.9M
26.8M
19.4M
OPERATING INCOME
(132.1M)
(115.3M)
(98.5M)
(76.4M)
(61.8M)
(53.3M)
(46.8M)
(31.5M)
(20.6M)
(14.1M)
(16.7M)
(9.9M)
(121.4M)
(112.5M)
(93.7M)
(73.4M)
(60M)
(57.7M)
(45.3M)
(30.9M)
(20.2M)
(13.8M)
(16.7M)
(9.6M)
(3M)
(3.1M)
(2.8M)
(2.7M)
(2.1M)
(1.1M)
(848K)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
21.8M
17.9M
14.3M
8.3M
11.6M
26.8M
8.7M
17M
8.8M
383K
10M
9.5M
PRE-TAX INCOME
(1.2M)
(776K)
(424K)
(197K)
(318K)
(509K)
(314K)
(181K)
(272K)
(323K)
(0.0)
(0.0)
-1.2M
-776K
-424K
-197K
-318K
-509K
-314K
-181K
-272K
-323K
0.0
0.0
(7.8M)
-249K
(1.9M)
(369K)
-323K
-5.5M
(671K)
-71K
(402K)
(332K)
(0.0)
(0.0)
-67K
-1.7M
61K
738K
923K
-418K
-61K
-386K
-633K
-274K
-87K
-34K
21.8M
16.2M
14.4M
9M
12.5M
26.4M
8.8M
10.3M
8.2M
109K
10M
9.5M
NET INCOME
(6.4M)
(4.8M)
(4.1M)
(2.8M)
(3.4M)
-5.2M
(271K)
(162K)
(15K)
-1.1M
(1M)
(0.0)
14.9M
11.3M
10.2M
6.2M
9.1M
31.5M
8.5M
10.2M
8.2M
1.2M
8.9M
9.5M

SEC Filings

VMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

June 02, 2026
June 02, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 05, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 05, 2026
May 05, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 22, 2026
April 22, 2026
2026
8-K

8-K 2026

N/A

March 16, 2026
March 16, 2026
2026
10-K

10-K 2025 FY

FY

March 04, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 04, 2026
March 04, 2026
2026
8-K

8-K 2025

N/A

November 07, 2025
November 07, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 05, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 05, 2025
November 05, 2025
2025
Showing 1 to 10 of 126 filings